| Year |
Citation |
Score |
| 2022 |
Shevachman M, Mandal A, Gelston K, Mitragotri S, Joshi N. A Long-Lasting Skin Protectant Based on CG-101, a Deep Eutectic Solvent Comprising Choline and Geranic Acid. Global Challenges (Hoboken, Nj). 6: 2200064. PMID 36381128 DOI: 10.1002/gch2.202200064 |
0.412 |
|
| 2021 |
Ko J, Mandal A, Dhawan S, Shevachman M, Mitragotri S, Joshi N. Clinical translation of choline and geranic acid deep eutectic solvent. Bioengineering & Translational Medicine. 6: e10191. PMID 34027084 DOI: 10.1002/btm2.10191 |
0.461 |
|
| 2020 |
Zhao Z, Ukidve A, Krishnan V, Fehnel A, Pan DC, Gao Y, Kim J, Evans MA, Mandal A, Guo J, Muzykantov VR, Mitragotri S. Systemic tumour suppression via the preferential accumulation of erythrocyte-anchored chemokine-encapsulating nanoparticles in lung metastases. Nature Biomedical Engineering. PMID 33199847 DOI: 10.1038/s41551-020-00644-2 |
0.601 |
|
| 2020 |
Mandal A, Kumbhojkar N, Reilly C, Dharamdasani V, Ukidve A, Ingber DE, Mitragotri S. Treatment of psoriasis with NFKBIZ siRNA using topical ionic liquid formulations. Science Advances. 6: eabb6049. PMID 32832675 DOI: 10.1126/Sciadv.Abb6049 |
0.485 |
|
| 2020 |
Ukidve A, Zhao Z, Fehnel A, Krishnan V, Pan DC, Gao Y, Mandal A, Muzykantov V, Mitragotri S. Erythrocyte-driven immunization via biomimicry of their natural antigen-presenting function. Proceedings of the National Academy of Sciences of the United States of America. PMID 32665441 DOI: 10.1073/Pnas.2002880117 |
0.489 |
|
| 2020 |
Mandal A, Clegg JR, Anselmo AC, Mitragotri S. Hydrogels in the clinic. Bioengineering & Translational Medicine. 5: e10158. PMID 32440563 DOI: 10.1002/btm2.10158 |
0.459 |
|
| 2020 |
Dharamdasani V, Mandal A, Qi QM, Suzuki I, Bentley MVLB, Mitragotri S. Topical delivery of siRNA into skin using ionic liquids. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 32339547 DOI: 10.1016/J.Jconrel.2020.04.038 |
0.469 |
|
| 2019 |
Alshamrani M, Sikder S, Coulibaly F, Mandal A, Pal D, Mitra AK. Self-Assembling Topical Nanomicellar Formulation to Improve Curcumin Absorption Across Ocular Tissues. Aaps Pharmscitech. 20: 254. PMID 31317354 DOI: 10.1208/S12249-019-1404-1 |
0.533 |
|
| 2019 |
Mandal A, Patel P, Pal D, Mitra AK. Multi-Layered Nanomicelles as Self-Assembled Nanocarrier Systems for Ocular Peptide Delivery. Aaps Pharmscitech. 20: 66. PMID 30627825 DOI: 10.1208/S12249-018-1267-X |
0.515 |
|
| 2019 |
Mandal A, Gote V, Pal D, Ogundele A, Mitra AK. Ocular Pharmacokinetics of a Topical Ophthalmic Nanomicellar Solution of Cyclosporine (Cequa®) for Dry Eye Disease. Pharmaceutical Research. 36: 36. PMID 30617777 DOI: 10.1007/S11095-018-2556-5 |
0.525 |
|
| 2019 |
Patel P, Mandal A, Gote V, Pal D, Mitra AK. Thermosensitive hydrogel-based drug delivery system for sustained drug release Journal of Polymer Research. 26. DOI: 10.1007/S10965-019-1771-Z |
0.564 |
|
| 2018 |
Mandal A. Ocular delivery of proteins and peptides: Challenges and novel formulation approaches. Adv Drug Deliv Rev. PMID 29339145 DOI: 10.1016/j.addr.2018.01.008 |
0.307 |
|
| 2018 |
Mandal A, Pal D, Agrahari V, Trinh HM, Joseph M, Mitra AK. Ocular delivery of proteins and peptides: challenges and novel formulation approaches. Advanced Drug Delivery Reviews. PMID 29339145 DOI: 10.1016/J.Addr.2018.01.008 |
0.556 |
|
| 2017 |
Agrahari V, Li G, Agrahari V, Navarro I, Perkumas K, Mandal A, Stamer WD, Mitra AK. Pentablock copolymer dexamethasone nanoformulations elevate MYOC: in vitro liberation, activity and safety in human trabecular meshwork cells. Nanomedicine (London, England). 12: 1911-1926. PMID 28756742 DOI: 10.2217/Nnm-2017-0140 |
0.593 |
|
| 2017 |
Mandal A, Cholkar K, Khurana V, Shah A, Agrahari V, Bisht R, Pal D, Mitra AK. Topical formulation of self-assembled antiviral prodrug nanomicelles for targeted retinal delivery. Molecular Pharmaceutics. PMID 28471177 DOI: 10.1021/Acs.Molpharmaceut.7B00128 |
0.665 |
|
| 2017 |
Bisht R, Mandal A, Jaiswal JK, Rupenthal ID. Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. PMID 28425224 DOI: 10.1002/Wnan.1473 |
0.689 |
|
| 2017 |
Mandal A. Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies J Control Release. PMID 28087407 DOI: 10.1016/j.jconrel.2017.01.012 |
0.395 |
|
| 2017 |
Mandal A, Bisht R, Rupenthal ID, Mitra AK. Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 28087407 DOI: 10.1016/J.Jconrel.2017.01.012 |
0.717 |
|
| 2016 |
Agrahari V, Agrahari V, Mandal A, Pal D, Mitra AK. How are we improving the delivery to back of the eye? Advances and challenges of novel therapeutic approaches. Expert Opinion On Drug Delivery. PMID 27967247 DOI: 10.1080/17425247.2017.1272569 |
0.574 |
|
| 2016 |
Agrahari V, Mandal A, Agrahari V, Trinh HM, Joseph M, Ray A, Hadji H, Mitra R, Pal D, Mitra AK. A comprehensive insight on ocular pharmacokinetics. Drug Delivery and Translational Research. PMID 27798766 DOI: 10.1007/S13346-016-0339-2 |
0.571 |
|
| 2016 |
Mandal A, Pal D, Mitra AK. Circumvention of P-gp and MRP2 mediated efflux of lopinavir by a histidine based dipeptide prodrug. International Journal of Pharmaceutics. PMID 27543355 DOI: 10.1016/J.Ijpharm.2016.08.027 |
0.41 |
|
| 2016 |
Mandal A, Agrahari V, Khurana V, Pal D, Mitra AK. Transporter effects on cell permeability in drug delivery. Expert Opinion On Drug Delivery. PMID 27449574 DOI: 10.1080/17425247.2016.1214565 |
0.661 |
|
| 2016 |
Bisht R, Mandal A, Rupenthal ID, Mitra AK. Ex vivo investigation of ocular tissue distribution following intravitreal administration of connexin43 mimetic peptide using the microdialysis technique and LC-MS/MS. Drug Delivery and Translational Research. PMID 27371395 DOI: 10.1007/S13346-016-0308-9 |
0.631 |
|
| 2015 |
Mandal A, Patel M, Sheng Y, Mitra AK. Design of lipophilic prodrugs to improve drug delivery and efficacy. Current Drug Targets. PMID 26648076 DOI: 10.2174/1389450117666151209115431 |
0.645 |
|
| 2015 |
Vaishya R, Mandal A, Patel S, Mitra AK. Extended Release microparticle-in-gel Formulation of Octreotide: Effect of polymer type on acylation of Peptide during in vitro release. International Journal of Pharmaceutics. PMID 26561725 DOI: 10.1016/J.Ijpharm.2015.11.002 |
0.514 |
|
| 2015 |
Mitra AK, Agrahari V, Mandal A, Cholkar K, Natarajan C, Shah S, Joseph M, Trinh HM, Vaishya R, Yang X, Hao Y, Khurana V, Pal D. Novel delivery approaches for cancer therapeutics. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 26456750 DOI: 10.1016/J.Jconrel.2015.09.067 |
0.664 |
|
| 2015 |
Ray A, Mandal A, Joseph M, Mitra AK. Recent patents on nanoparticles and nanoformulations for cancer therapy. Recent Patents On Drug Delivery & Formulation. PMID 26282464 DOI: 10.2174/1872211309666150818110846 |
0.507 |
|
| 2015 |
Ray A, Mandal A, Mitra AK. Recent patents in pulmonary delivery of macromolecules. Recent Patents On Drug Delivery & Formulation. PMID 26219931 DOI: 10.2174/1872211309666150729122231 |
0.575 |
|
| 2015 |
Vaishya RD, Mandal A, Gokulgandhi M, Patel S, Mitra AK. Reversible hydrophobic ion-paring complex strategy to minimize acylation of octreotide during long-term delivery from PLGA microparticles. International Journal of Pharmaceutics. 489: 237-45. PMID 25940041 DOI: 10.1016/J.Ijpharm.2015.04.075 |
0.712 |
|
| 2014 |
Gilger BC, Mandal A, Shah S, Mitra AK. Episcleral, intrascleral, and suprachoroidal routes of ocular drug delivery - recent research advances and patents. Recent Patents On Drug Delivery & Formulation. 8: 81-91. PMID 25001638 DOI: 10.2174/187221130802140707093509 |
0.694 |
|
| Show low-probability matches. |